TABLE 2.
Least-squares adjusted means ± SE of log-transformed circulating metabolite values across increasing quartiles of dairy intake in the Framingham Heart Study Offspring cohort, total sample (n = 2205)1
| Quartile category of dairy intake | ||||||||
|---|---|---|---|---|---|---|---|---|
| Metabolite | Q1 | Q2 | Q3 | Q4 | P-trend | Sig.2 | In Gen33 | |
| Number in quartile category | 551 | 551 | 552 | 551 | ||||
| Total dairy (quartile median, servings/wk) | n | 2.5 | 6.5 | 10.4 | 20.0 | |||
| C18:1 LPE | 1818 | 0.402 ± 0.026 | 0.368 ± 0.024 | 0.365 ± 0.024 | 0.343 ± 0.025 | 0.05 | N | n/a |
| C18:2 LPE | 1818 | 0.043 ± 0.026 | 0.039 ± 0.025 | 0.026 ± 0.024 | −0.013 ± 0.026 | 0.03 | N | n/a |
| C54:3 TAG | 1818 | 0.326 ± 0.021 | 0.321 ± 0.019 | 0.318 ± 0.019 | 0.302 ± 0.020 | 0.26 | N | n/a |
| C56:3 TAG | 1818 | 0.443 ± 0.031 | 0.440 ± 0.029 | 0.443 ± 0.029 | 0.408 ± 0.030 | 0.25 | N | n/a |
| cis/trans-Hydroxyproline | 2202 | 0.241 ± 0.023 | 0.195 ± 0.022 | 0.190 ± 0.021 | 0.143 ± 0.022 | 0.0002 | Y | P = 0.44 |
| Gentisate | 1816 | −0.553 ± 0.066 | −0.574 ± 0.062 | −0.618 ± 0.061 | −0.612 ± 0.064 | 0.40 | N | n/a |
| Glycodeoxycholates | 1816 | 0.092 ± 0.056 | 0.020 ± 0.053 | 0.024 ± 0.052 | −0.070 ± 0.055 | 0.01 | N | n/a |
| Pantothenate | 1816 | 0.040 ± 0.034 | 0.075 ± 0.032 | 0.125 ± 0.031 | 0.193 ± 0.033 | <0.0001 | Y | P = 0.0484 |
| Taurodeoxycholates | 1809 | 0.027 ± 0.067 | −0.015 ± 0.063 | −0.029 ± 0.062 | −0.071 ± 0.065 | 0.18 | N | P = 0.87 |
| Uridine | 1816 | −0.250 ± 0.017 | −0.214 ± 0.016 | −0.198 ± 0.016 | −0.140 ± 0.016 | <0.0001 | Y | P = 0.0014 |
| Niacinamide | 2202 | 0.195 ± 0.028 | 0.234 ± 0.026 | 0.184 ± 0.026 | 0.257 ± 0.028 | 0.07 | N | P = 0.49 |
| Milk (quartile median, servings/wk) | 0.0 | 3.0 | 5.5 | 17.5 | ||||
| C46:0 TAG | 1559 | −0.127 ± 0.043 | −0.122 ± 0.043 | −0.078 ± 0.042 | −0.079 ± 0.043 | 0.34 | N | n/a |
| cis/trans-Hydroxyproline | 2202 | 0.229 ± 0.022 | 0.186 ± 0.022 | 0.196 ± 0.022 | 0.154 ± 0.022 | 0.006 | Y | P = 0.75 |
| Pantothenate | 1816 | 0.046 ± 0.033 | 0.059 ± 0.033 | 0.163 ± 0.032 | 0.165 ± 0.033 | 0.001 | Y | P = 0.98 |
| Uridine | 1816 | −0.246 ± 0.016 | −0.222 ± 0.016 | −0.196 ± 0.016 | −0.148 ± 0.016 | <0.0001 | Y | P = 0.10 |
| Cream/butter (quartile median, servings/wk) | 0.0 | 0.9 | 3.0 | 13.4 | ||||
| C54:4 TAG | 1818 | 0.137 ± 0.017 | 0.110 ± 0.017 | 0.095 ± 0.016 | 0.043 ± 0.017 | <0.0001 | Y | n/a |
| Pyridoxate | 1814 | 0.110 ± 0.047 | 0.041 ± 0.045 | 0.170 ± 0.045 | 0.029 ± 0.046 | 0.11 | N | n/a |
| Cheese (quartile median, servings/wk) | 0.5 | 1.0 | 3.0 | 5.5 | ||||
| C14:0 LPC | 1818 | 0.071 ± 0.027 | 0.103 ± 0.026 | 0.128 ± 0.026 | 0.149 ± 0.027 | 0.01 | N | n/a |
| C44:1 TAG | 1818 | −0.521 ± 0.075 | −0.445 ± 0.074 | −0.402 ± 0.073 | −0.294 ± 0.077 | 0.008 | N | n/a |
| C46:0 TAG | 1559 | −0.144 ± 0.043 | −0.151 ± 0.042 | −0.098 ± 0.042 | −0.004 ± 0.044 | 0.001 | Y | n/a |
| C54:3 TAG | 1818 | 0.341 ± 0.020 | 0.315 ± 0.019 | 0.323 ± 0.019 | 0.297 ± 0.020 | 0.10 | N | n/a |
| C54:4 TAG | 1818 | 0.123 ± 0.017 | 0.104 ± 0.017 | 0.096 ± 0.016 | 0.067 ± 0.017 | 0.004 | Y | n/a |
| C54:5 TAG | 1818 | 0.017 ± 0.022 | −0.019 ± 0.021 | −0.024 ± 0.021 | −0.059 ± 0.022 | 0.005 | Y | n/a |
| C54:6 TAG | 1818 | 0.017 ± 0.022 | −0.019 ± 0.021 | −0.024 ± 0.021 | −0.059 ± 0.022 | 0.005 | Y | n/a |
| Yogurt (quartile median, servings/wk) | 0.0 | 0.0 | 0.5 | 3.0 | ||||
| C20:5 CE | 1818 | −0.420 ± 0.043 | −0.376 ± 0.039 | −0.354 ± 0.040 | −0.263 ± 0.040 | 0.001 | Y | n/a |
| C20:5 LPC | 1818 | −0.099 ± 0.036 | −0.099 ± 0.033 | −0.050 ± 0.034 | −0.017 ± 0.034 | 0.03 | N | n/a |
| C58:11 TAG | 1818 | 0.324 ± 0.036 | 0.315 ± 0.033 | 0.345 ± 0.034 | 0.392 ± 0.034 | 0.03 | N | n/a |
| Pyridoxate | 1814 | 0.022 ± 0.049 | 0.062 ± 0.045 | 0.111 ± 0.047 | 0.168 ± 0.046 | 0.01 | N | n/a |
| Salicylurate | 1814 | 0.804 ± 0.116 | 0.673 ± 0.106 | 0.735 ± 0.109 | 0.859 ± 0.109 | 0.17 | N | n/a |
Metabolite values are log-transformed. Model adjusted for age, sex, BMI, smoking status, history of diabetes, history of cardiovascular disease, intake of other dairy (except in total dairy; i.e., for milk, the model included cheese, cream/butter, and yogurt), and intake of fish, fruit, vegetables, meat, and nuts, as well as batch or plate (as applicable). Conversion of standard serving sizes to grams for dairy is as follows: skim milk, 245 g; whole milk, 245 g; cream, 15 g; sour cream, 12 g; sherbet/ice milk, 96 g; ice cream, 66 g; yogurt, 227 g; cottage/ricotta cheese, 105 g; cream cheese, 28 g; other cheese, 28 g; butter, 5 g. CE, cholesterol ester; Gen3, Framingham Heart Study Third Generation cohort; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; n/a, not available; Q, quartile; TAG, triacylglycerol.
Significant after Bonferroni correction: P < 0.05/11 (0.0045) for total dairy; <0.05/4 (0.0125) for milk; <0.05/2 (0.025) for cream/butter; <0.05/7 (0.007) for cheese; <0.05/5 (0.01) for yogurt.
Tested in identical models in Gen3 total sample, where metabolite value was measured and annotated. See also Supplemental Table 4.
Association in Gen3 was directionally consistent with that in the Offspring. See also Supplemental Table 4.